Akari’s priority pipeline programs remain on track to begin enrollment in the registrational nomacopan Phase 3 clinical trials in pediatric…
LONDON and SALT LAKE CITY, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled…
$3 million awarded by DoD to University of North Carolina Institute of Trauma Recovery to support a proposed 180-patient, randomized,…
Two prospective, peer reviewed trials demonstrate the symptomatic benefit of gammaCore in patients with PTSDROCKAWAY, N.J., Sept. 27, 2023 (GLOBE…
PBIO Acknowledges Rapidly Emerging Demand Potential for UltraShear Nanoemulsions for Transformation of Diverse Major Markets, with Recently Announced Readiness and…
SAN DIEGO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited (“Conduit Pharmaceuticals”), a multi-asset clinical-stage disease-agnostic life science company…
TEXARKANA, Ark., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Ark-la-Tex Health Center is now offering a revolutionary new method in healing,…
Further Innovations Announced, with All Systems Go for Fulfilling Current and Future Orders; UltraShear is No Longer Just the Name…
New Module Automates Regulatory Updates During Corporate TransitionsLOS ANGELES, CA / ACCESSWIRE / September 19, 2023 / Today, LighthouseAI™, a…
- Consilium to combine with ICR’s US-based healthcare practice, providing clients with seamless integrated support for strategic communications and investor…